Back to Ameriprise Financial Inc. Ameriprise Financial Inc.

AUPHAUPH

Showing 8 of 14 quarters

Position history for Ameriprise Financial Inc.Ameriprise Financial Inc.'s holdings in Aurinia Pharmaceuticals Inc

Yes. Ameriprise Financial holds 11,053 shares of AUPH (Aurinia Pharmaceuticals), worth $187,570, as of its Q2 2026 13F filing. It reduced the position by 33,395 shares (-75.1%) from Q1 2026. Ameriprise Financial has held AUPH since Q2 2024, across 9 quarterly 13F filings.

Current Value

$187,570

Current Shares

11,053

Total Value Change

+$108,296

Total Shares Change

+238

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
11,053
-75.1%
$187,5700.0%$16.97
0
2026-Q1
Increased
44,448
+319.2%
$658,7200.0%$14.82
40
2025-Q4
Decreased
10,603
-0.1%
$169,1180.0%$15.95
0
2025-Q3
Decreased
10,608
-92.1%
$117,2180.0%$11.05
0
2025-Q2
Increased
134,303
+327.5%
$1.1M0.0%$8.47
41
2025-Q1
Decreased
31,415
-16.9%
$252,5770.0%$8.04
0
2024-Q4
Increased
37,796
+249.5%
$339,4080.0%$8.98
38
2024-Q3
Increased
10,815
+1.2%
$79,2740.0%$7.28
15

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used